Member Exclusive NEWS ROUND-UP

Cell therapy weekly: New hurdle in immunotherapy development

This week in cell therapy: Kymriah will be available for children but not adults on the NHS and CRISPR Therapeutics and ViaCyte will collaborate on the development of gene-edited diabetes therapy.

Go to the profile of RegMedNet
Sep 20, 2018
0
0

Please sign in or register for FREE

No comments yet.